ACRP is pleased to welcome David M. Vulcano, a long-time volunteer and thought leader in the clinical research enterprise, as its new Chief Executive Officer.
“You cannot lead an organization beyond your capacity to lead yourself,” said career coach Muriel Maignan Wilkins, CEO and Founder of Paravis Partners, as she and other expert panelists offered advice and insights on leadership as a clinical trial competency during a Signature Series gathering on Sunday (April 26) at ACRP 2026 in Orlando.
As the ACRP 2026 schedule came to a close in Orlando on Monday (April 27), Signature Series speaker David Burrow, PharmD, JD, Director, Office of Scientific Investigations, U.S. Food and Drug Administration (FDA), urged his audience to “act with courage, driven by purpose” and to take Sun Tzu’s philosophy about finding opportunity in the midst of chaos to heart.
With due consideration to the late writer Maya Angelou’s paraphrased sentiment that “you can’t really know where you’re going until you know where you’ve been,” Signature Series panelists who gathered at ACRP 2026 in Orlando on Saturday (April 25) weighed in on the theme of “Embrace the Now, Ignite What’s Next” for the clinical research enterprise.
Advocating for awareness of clinical research, with all of its possible career options, in public and policy-making circles is an often quiet but mighty endeavor, but one lately being taken on at ever greater volume by a variety of cheerleaders. Some of the most vocal boosters are part of ACRP’s Partners Advancing the Clinical Research Workforce, a multi-stakeholder collaborative of industry leaders who are committed to building a diverse, research-ready workforce for the enterprise and who met to present updates on their initiatives during ACRP 2026 in Orlando.